These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 21412768

  • 1. Alteration of G1/S transition regulators influences recurrences in head and neck squamous carcinomas.
    Canzonieri V, Barzan L, Franchin G, Vaccher E, Talamini R, Sulfaro S, Baldassarre G.
    J Cell Physiol; 2012 Jan; 227(1):233-8. PubMed ID: 21412768
    [Abstract] [Full Text] [Related]

  • 2. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M.
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A.
    Cancer Res; 1995 Mar 01; 55(5):975-8. PubMed ID: 7867006
    [Abstract] [Full Text] [Related]

  • 4. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD, Smee R, Rees CG, Salardini A, Eggleton S, Yang JL, Russell PJ.
    ANZ J Surg; 2009 Mar 01; 79(1-2):48-54. PubMed ID: 19183379
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S, El-Naggar AK.
    Lab Invest; 1999 Mar 01; 79(3):255-60. PubMed ID: 10092061
    [Abstract] [Full Text] [Related]

  • 6. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Jun 01; 23(2):277-83. PubMed ID: 15354413
    [Abstract] [Full Text] [Related]

  • 7. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM.
    J Pathol; 2009 Mar 01; 217(4):516-23. PubMed ID: 18991334
    [Abstract] [Full Text] [Related]

  • 8. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.
    Laryngoscope; 2002 Mar 01; 112(3):472-81. PubMed ID: 12148857
    [Abstract] [Full Text] [Related]

  • 9. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY.
    Mod Pathol; 2003 Sep 01; 16(9):944-50. PubMed ID: 13679459
    [Abstract] [Full Text] [Related]

  • 10. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 01; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 11. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Kalish LH, Nguyen TV, Kench JG, Bova RJ, Cole IE, Musgrove EA, Sutherland RL.
    Clin Cancer Res; 2005 Jun 01; 11(11):4107-16. PubMed ID: 15930346
    [Abstract] [Full Text] [Related]

  • 12. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 13. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
    Sabah M, Cummins R, Leader M, Kay E.
    Hum Pathol; 2006 Jun 10; 37(6):648-55. PubMed ID: 16733203
    [Abstract] [Full Text] [Related]

  • 14. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N.
    Anticancer Res; 2000 Jun 10; 20(1A):337-44. PubMed ID: 10769677
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
    Peters MG, Vidal Mdel C, Giménez L, Mauro L, Armanasco E, Cresta C, Bal de Kier Joffé E, Puricelli L.
    Oncol Rep; 2004 Nov 10; 12(5):1143-50. PubMed ID: 15492807
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 17. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
    Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J.
    Cancer Res; 1995 Feb 15; 55(4):949-56. PubMed ID: 7850812
    [Abstract] [Full Text] [Related]

  • 18. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.
    Krecicki T, Smigiel R, Fraczek M, Kowalczyk M, Sasiadek MM.
    J Laryngol Otol; 2004 Sep 15; 118(9):676-80. PubMed ID: 15509364
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Nguyen TV, Bova RJ, Kench JG, Cole IE, Musgrove EA, Henshall SM, Sutherland RL.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3705-11. PubMed ID: 14506162
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.